RxDoctor Payments Data

Alexandra Spangler, DPM

Podiatrist · Glen Burnie, MDNPI 1518497023

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (54.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Supreme Orthopedic Systems, LLC at 56.6% of the total. Reporting peaked in 2021 at $4,851 and has fallen 87.1% since, to $625 in 2025. Among podiatrist clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,762in general payments, 2019–2025

Across 60 payments — averaging $146.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Supreme Orthopedic Systems, LLC$5K
  • Stryker$2K
  • Zimmer Biomet$905
  • Reapplix Inc.$286
  • Integra Lifesciences Corporation$236
  • Smith+Nephew$236
  • plus $638 from 13 others

What the payments were for

  • Travel & lodging$1,46817%
  • Food & beverage$2,40627%
  • Education$4,80055%
  • Other$881%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,762 in reported general payments places this provider in the 90th percentile of 183 podiatrist providers in Maryland.

See all podiatrist providers in Maryland

Medicare billing

Part B allowed, 2024
$99,937
Medicare patients
320
Services billed
931

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox74$3,711
Ammonium Lactate52$1,651
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip42$955
Ketoconazole28$732
Methylprednisolone25$255
Mupirocin28$254
Terbinafine Hcl38$232
Meloxicam28$145
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen14$59

Paid to pharmacies, not to this prescriber.

Other podiatrist in Glen Burnie

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →